Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to investigate the performance of a new voice prosthesis in comparison with the Provox2 and the Provox ActiValve voice prosthesis in 15 laryngectomized patients. Factors taken into account are clinician and patient satisfaction with the insertion system, patient satisfaction with voice, speech, performance, and maintenance. Voice and speech will also be evaluated for the different prostheses by means of perceptual evaluations and acoustic analysis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00743262
Study type Interventional
Source Atos Medical AB
Contact
Status Completed
Phase Phase 1/Phase 2
Start date April 2008
Completion date April 2009

See also
  Status Clinical Trial Phase
Completed NCT04491487 - Pre-operative Counselling in Laryngectomized Patients N/A
Terminated NCT01948219 - ENTegral Artificial Larynx Clinical Trial N/A
Completed NCT02601638 - Laryngectomy Education N/A
Recruiting NCT05489965 - Gender Disparities in Voice Outcomes After Tracheoesophageal Puncture in Total Laryngectomy Patients (UC Davis)
Recruiting NCT04650919 - Aortic Laryngeal Rehabilitation Graft N/A
Terminated NCT00661570 - Long-term Clinical Feasibility of the New Indwelling Provox Vega 20 Voice Prosthesis Phase 2
Completed NCT02739958 - Effects of Propofol-dexmedetomidine on Immune Function in Patients With Cancer Larynx N/A
Completed NCT00942903 - Short-term Clinical Feasibility of the Provox XtraHMEs for Pulmonary Rehabilitation After Total Laryngectomy Phase 1
Completed NCT00884910 - Long Term Use of the Provox Vega 22.5 Phase 2